Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
abdominal protrusion
acetylcholine
acromegaly
advances in neurology
adverse drug reaction
affective disorders
agitation
akathisia
algorithm
alpha methyldopa hydrazine
Alzheimer's disease
amantadine
amitriptyline
amphetamines
amphetamines, dyskinesia associated with
amygdala
anesthesia, general
anticholinergic drugs
anticholinergic drugs, side effects of
antidepressant
antihistamines
anxiety
apomorphine
aprazolam
arrhythmia, cardiac
aspartate aminotransferase
asterixis
atypical
autonomic dysfunction
axillary nerve
ballismus, bilateral
behavioral disorder
benzodiazepine
bladder dysfunction
bradykinesia
bromocriptine
Brueghel's syndrome
burning paresthesia
buspirone
carbidopa
CAT scan, emission
catechol-o-methyltransferase inhibitor
chest pain
chorea
clonazepam
clozapine
complications
confusion
controversies in neurology
Coombs test, positive
cough
delirium
delusion
dementia
deprenyl
depression
desipramine
diabetes mellitus
diarrhea
dopamine
dopamine agonist
drug abuse
drug addiction
drug holiday
drug induced neurologic disorders
drug interactions
drug withdrawal
dyskinesia
dyskinesia, buccal lingual facial
dyskinesia, drug induced
dyspnea
dystonia
dystonia, treatment of
efficacy
electroencephalogram
electroencephalogram, abnormalities of
electroencephalogram, periodic complexes
electroencephalogram, triphasic delta waves
encephalopathy
entacapone
enzyme inhibition
enzyme, serum
epidemiology of neurology
excitotoxin
genetic neurologic disorders
globus pallidus, stimulation
groaning
hallucination
hallucination, visual
haloperidol
hemiballismus
hemidystonia
hunger
hyperthermia
iatrogenic neurologic disorders
imipramine
infusion pump
intellectual deficit
isoniazid
L-dopa
L-dopa, controlled release
L-dopa, delayed treatment in Parkinsonism
L-dopa, drug interactions with and side effects of
L-dopa, enteral infusion, continuous
L-dopa, plasma concentration
L-dopa, potentiators of
Lewy body
Lewy body disease, diffuse
livedo reticularis
liver function enzymes
locus ceruleus, lesion of
lorazepam
manic-depressive
melanoma, malignant
memory
memory, impairment of
mental status, abnormal
mitochondrial disease
monoamine oxidase inhibitors
mortality
movement disorder
movement disorder, drug induced
movement disorder, extrapyramidal
movement disorder, treatment of
MRI
myoclonic jerks
myoclonus
myoclonus, sleep
nausea and vomiting
neuroendocrinology
neuroleptic
neuroleptic malignant syndrome
neuroleptic, atypical
neurologic complications of, surgery
neurologic signs
neurologist
neuronal degeneration
neuropathology
nigrostriatal pathway
nortriptyline
olanzapine
ondansetron
oral contraceptives
oral contraceptives, choreiform movements with
orthostatic hypotension
pain
pallidotomy
panic attacks
papaverine
paranoia
paresthesias
Parkinson disease
Parkinson disease, complications, late
Parkinson disease, dementia with
Parkinson disease, diagnosis
Parkinson disease, differential diagnosis of
Parkinson disease, drug holiday
Parkinson disease, dystonia with
Parkinson disease, early symptoms
Parkinson disease, fluctuations in
Parkinson disease, nonmotor problems of
Parkinson disease, on-off phenomena in
Parkinson disease, pathogenesis of
Parkinson disease, postencephalitic
Parkinson disease, sensory symptoms in
Parkinson disease, surgical treatment of
Parkinson disease, treatment of
Parkinson disease, young onset
Parkinsonism plus syndrome
Parkinsonism syndrome
parsidol
patient information and support
pergolide
phenothiazine
phenothiazine, dyskinesia associated with
phobias
pramipexole
procyclidine
progressive supranuclear palsy
psychiatric disorder
psychiatric problems in neurologic disorders
psychosis
psychotic behavior
pyridoxine
quetiapine
raphe nuclei
reserpine and reserpine like drugs
reserpine treatment in movement disorder
respirations in CNS disease
respiratory dyskinesias
review article
rigidity
ritalin
ropinirole
selective serotonin reuptake inhibitors
serotonin antagonist
serum alanine aminotransferase
sinemet
single photon emission computed tomography
sleep pathology and physiology
start hesitation
stimulation, deep brain
substantia nigra
subthalamic nucleus
subthalamic nucleus deep brain stimulation
tardive dyskinesia
tolcapone
tonic foot response
torticollis
trazodone
treatment of neurologic disorder
tremor
tremor, thalamic stimulation for suppression of
tricyclic antidepressant
trigeminal neuralgia
vitamin, multiple
vocalizations
Showing articles 100 to 150 of 982 << Previous Next >>

Restless Arms
Lancet 371:530, Horvath,J.,et al, 2008

Fourteen-Year Final Report of the Randomized PDRG-UK Trial Comparing Three Treatments in PD
Neurol 71:474-480.470, Katzenschlager,R.,et al., 2008

Functional Abnormalities Underlying Pathological Gambling in Parkinson Disease
Arch Neurol 65:1604-1611, Cilia,R.,et al, 2008

Levodopa for the Treatment of Parkinsons Disease
NEJM 359:2468-2476, LeWitt,P.A., 2008

Ropinirole 24-Hour Prolonged Release: Randomized, Controlled Study in Advanced Parkinson Disease
Neurol 68:1108-1115, Pahwa,R.,et al, 2007

Treatment Options in the Modern Management of Parkinson Disease
Arch Neurol 64:1083-1088, Schapira,A.H.V., 2007

Compulsive Singing: Another Aspect of Punding in Parkinsons Disease
Ann Neurol 62:525-528, Bonvin,C.,et al, 2007

Vascular Parkinsonism and Dementia in a CADASIL Case with Intact Nigrostriatal Dopaminergic System
Akt Neurol 33: Suppl, Wegner,F.,et al, 2006

Benign Tremulous Parkinsonism
Arch Neurol 63:354-357,321, Josephs,K.A.,et al, 2006

Practice Parameter: Diagnosis and Prognosis of New Onset Parkinson Disease (An Evidence-Based Review)
Neurol 66:968-975, Suchowersky,O.,et al, 2006

Practice Parameter: Neuroprotective Strategies and Alternative Therapies for Parkinson Disease (An Evidence-Based Review)
Neurol 66:976-982, Suchowersky,O.,et al, 2006

Clinicopath Conf, Dopamine-Responsive-Dystonia Caused by a Mutation in the GCH1 Gene
NEJM 355:831-839, Case 26-2006, 2006

Dopamine-Responsive Dystonia
eMedicine (Apr), Nikhar,N.K., 2006

Diagnosis and Management of Dementia with Lewy Bodies
Neurol 65:1863-1872, McKeith,I.G.,et al, 2005

The Role of Levodopa in the Management of Dementia With Lewy Bodies
JNNP 76:1200-1203, Moloy,S.,et al, 2005

Diagnosis and Initial Management of Parkinsons Disease
NEJM 353:1021-1027, Nutt,J.G.&Wooten,G.F., 2005

Rasagiline as an Adjunct to Levodopa in Patients With Parkinsons Disease and Motor Fluctuations (LARGO, Lasting Effect in Adjunct Therapy With Rasagiline Given Once Daily, Study)
Lancet 365:947-954, 914, Rascol,O., et al, 2005

Short-Term Paroxetine Treatment Does Not Alter the Motor Response to Levodopa in PD
Neurol 64:1797-1798, Chung,K.A.,et al, 2005

A Randomized Placebo-Controlled Trial of Rasagiline in Levodopa-Treated Patients with Parkinson Disease and Motor Fluctuations
Arch Neurol 62:241-248, The PRESTO Study, 2005

Effect of Levodopa Treatment for Parkinsonism in Welders
Neurol 62:730-733, Koller,W.C.,et al, 2004

Stalevo for Parkinson's Disease
The Medical Letter 46:39, , 2004

Clinicopath Conf, Multiple-System Atrophy
NEJM 351:912-921, Case 27-2004, 2004

Treatments of Parkinson Disease
Arch Neurol 60:1680-1684, Shults,C.W., 2003

Awakenings From Persistent Vegetative State: Report of Three Cases With Parkinsonism and Brain Stem Lesions on MRI
JNNP 74:1571-1573, Matsuda,W.,et al, 2003

Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003

Practice Parameter: Initiation of Treatment for Parkinson's Disease: An Evidence-based Review
Neurol 58:11-17, Miyasaki,J.M.,et al, 2002

Impact of Sustained Deprenyl (Selegiline) in Levodopa-Treated Parkinson's Disease: A Randomized Placebo-Controlled Extension of the Deprenyl and Tocopherol Antioxidative Therapy of Parkinsonism Trial
Ann Nuerol 51:604-612, Shoulson,I.,et al, 2002

Spinocerebellar Ataxia Type 2 Presenting as Familial Levodopa-Responsive Parkinsonism
Ann Neurol 50:812-815, Shan,D.,et al, 2001

Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001

Effects of Bilateral Subthalamic Nucleus Stimulation on Parkinsonian Gait
Neurol 57:144-146, Stolze,H.,et al, 2001

Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001

Axial Parkinsonian Symptoms Can Be Improved: The Role of Levodopa and Bilateral Subthalamic Stimulation
JNNP 68:595-600, Bejjani,B.P.,et al, 2000

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000

The Catechol-O-Methyltransferase (COMT) Inhibitor Entacapone Enhances the Pharmacokinetic and Clinical Response to Sinemet CR in Parkinson's Disease
JNNP 68:589-594, Piccinni,P.,et al, 2000

Clinical Correlates of Vascular Parkinsonism
Arch Neurol 56:98-102, Winikates,J.&Jancovic,J., 1999

Rapid-Onset Dystonia-Parkinsonism:Linkage to Chromosome 19q13
Ann Neurol 46:176-182, Kramer,P.L.,et al, 1999

Immediate-Release and Controlled-Release Carbidopa/Levodopa in PD, A 5-Year Randomized Multicenter Study
Neurol 53:1012-1019, Koller,W.C.,et al, 1999

Diagnostic Criteria for Parkinson Disease
Arch Neurol 56:33-39, Gelb,D.J.,et al, 1999

A Controlled Study of Additional sr-L-dopa in L-dopa-responsive Restless Legs Syndrome with Late-Night Symptoms
Neurol 52:285-290, Collado-Seidel,V.,et al, 1999

Random, Placebo-Contr Study of Tolcapone in Pts with Fluctuating Parkinson Dis Trtd With Levodopa-Carbidopa
Arch Neurol 55:1089-1095, Adler,C.H.,et al, 1998

Natural History & Survival of 14 Pts with Corticobasal Degeneration Confirmed as Postmortem Exam
JNNP 64:184-189, Wenning,G.K.,et al, 1998

Dopa-Responsive Dystonia, Some Pieces of the Puzzle are Still Missing
Neurol 50:853-855, Nygaard,T.G.&Wooten,G.F., 1998

Long-Term Follow-Up of Levodopa Responsiveness in Generalized Dystonia
Arch Neurol 55:1320-1323, Dewey,R.B.,et al, 1998

Depression, Palpitations, and Unilateral Pulsatile Tinnitus Due to a Dopamine-Secreting Glomus Jugulare Tumor
Am J Med 104:310-311, Troughton,R.W.,et al, 1998

Subcotical Arteriosclerotic Encephalopathy (Binswangers Disease)
, Ghika,J. &Bogousslavsky, J., 1998

Posteroventral Medial Pallidotomy in Levodopa-Unresponsive Parkinsonism
Arch Neurol 54:1026-1029, Krauss,J.K.,et al, 1997

COMT Inhibition with Tolcapone Reduces the"Wearing Off"Phenomenon & Levodopa Requirements in Fluctuating Parkinsonisn Pts
JNNP 63:421-428, Baas,H.,et al, 1997

Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997

Comparison of Extrapyramidal Features in 31 Path Cases of Diffuse Lewy Body Disease & 34 Cases of Parkinson's
Neurol 48:376-380, Louis,E.D.,et al, 1997

Sympathetic Cardioneuropathy in Dysautonomias
NEJM 336:696-702, 7211997., Goldstein,D.S.,et al, 1997



Showing articles 100 to 150 of 982 << Previous Next >>